These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 26324638
1. Detection by ELISA of C-terminal proBNP in plasma from cats with cardiomyopathy. Solter PF, Oyama MA, Machen MC, Trafny DJ, Sisson DD. Vet J; 2015 Nov; 206(2):213-7. PubMed ID: 26324638 [Abstract] [Full Text] [Related]
2. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. Fox PR, Rush JE, Reynolds CA, Defrancesco TC, Keene BW, Atkins CE, Gordon SG, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Macdonald KA, Lehmkuhl LB, Nguyenba TP, Sydney Moise N, Lefbom BK, Hogan DF, Oyama MA. J Vet Intern Med; 2011 Nov; 25(5):1010-6. PubMed ID: 21985136 [Abstract] [Full Text] [Related]
3. Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease. Harris AN, Beatty SS, Estrada AH, Winter B, Bohannon M, Sosa I, Hanscom J, Mainville CA, Gallagher AE. J Vet Intern Med; 2017 Jul; 31(4):994-999. PubMed ID: 28617995 [Abstract] [Full Text] [Related]
9. Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation. Machen MC, Oyama MA, Gordon SG, Rush JE, Achen SE, Stepien RL, Fox PR, Saunders AB, Cunningham SM, Lee PM, Kellihan HB. J Vet Cardiol; 2014 Dec; 16(4):245-55. PubMed ID: 25456274 [Abstract] [Full Text] [Related]
13. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF. J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287 [Abstract] [Full Text] [Related]
14. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study. Jung SW, Kittleson MD. J Vet Intern Med; 2011 May; 25(5):1044-9. PubMed ID: 21781160 [Abstract] [Full Text] [Related]
16. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations. Humm K, Hezzell M, Sargent J, Connolly DJ, Boswood A. J Small Anim Pract; 2013 Dec; 54(12):656-61. PubMed ID: 24283418 [Abstract] [Full Text] [Related]
17. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S. J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104 [Abstract] [Full Text] [Related]
18. Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy. Liu M, Köster LS, Fosgate GT, Chadwick CC, Sanz-González Í, Eckersall PD, Wotton PR, French AT. J Vet Intern Med; 2020 May; 34(3):1078-1090. PubMed ID: 32395893 [Abstract] [Full Text] [Related]
20. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay. Zaninotto M, Mion MM, Di Serio F, Caputo M, Ottomano C, Plebani M. Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]